PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohort

PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohort

Wang Y, Xiong C, Yu W, Zhou M, Shugg T, Hsu FC, Eadon MT, Su J, Song Q. Eur J Cancer. 2024 Dec;213:115114. doi: 10.1016/j.ejca.2024.115114. Epub 2024 Nov 9. PMID: 39536432; PMCID: PMC11798912.